Effects of magnesium, phosphate, or zinc supplementation in intensive care unit patients—A systematic review and meta‐analysis

GK Vesterlund, TS Jensen, KL Ellekjaer… - Acta …, 2023 - Wiley Online Library
Background Low‐serum levels of magnesium, phosphate, and zinc are observed in many
intensive care unit (ICU) patients, but clinical equipoise exists regarding supplementation …

Prolonged job strain and subsequent risk of cancer in women–a longitudinal study, based on the Danish Nurse Cohort

GK Vesterlund, BL Høeg, C Johansen… - Acta …, 2017 - Taylor & Francis
Background: The role of psychological stress in cancer risk is continuously debated. Stress
at work is the most common form of stress and previous studies have shown inconsistent …

Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxia: an international, randomized, blinded trial

…, MBN Kjær, MH Møller, TS Meyhoff, GK Vesterlund… - medRxiv, 2021 - medrxiv.org
IMPORTANCE Dexamethasone 6 mg daily is recommended for up to 10 days in patients
with severe and critical COVID-19, but a higher dose may benefit those with more severe …

Abnormal serum levels of magnesium, phosphate, and zinc in ICU patients—Characteristics, management, and outcomes: The WhyTrace cohort study

GK Vesterlund, HC Thorsen‐Meyer… - Acta …, 2023 - Wiley Online Library
… All authors contributed to the work; Gitte K. Vesterlund, Anders Perner, Morten H. Møller,
and Benjamin S. Kaas-Hansen conceptualisedconceptualized the study; Hans-Christian …

Preferences for the measurement and supplementation of magnesium, phosphate and zinc in ICUs: The international WhyTrace survey

GK Vesterlund, M Ostermann, SN Myatra… - Acta …, 2021 - Wiley Online Library
Background Patients admitted to the Intensive Care Unit (ICU) often have low magnesium,
phosphate and zinc levels. Monitoring of serum concentrations and supplementation may be …

[HTML][HTML] Heterogeneity of treatment effect of higher dose dexamethasone by geographic region (Europe vs. India) in patients with COVID-19 and severe hypoxemia–a …

…, MH Møller, TS Meyhoff, GK Vesterlund… - The Lancet Regional …, 2024 - thelancet.com
Background In the COVID-STEROID 2 trial there was suggestion of heterogeneity of treatment
effects (HTE) between patients enrolled from Europe vs. India on the primary outcome. …

Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID …

…, MH Moller, TS Meyhoff, GK Vesterlund… - Jama-Journal of the …, 2022 - pesquisa.bvsalud.org
Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support
in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial …

[PDF][PDF] Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia–the COVID STEROID Trial

…, TS Jensen, A Granholm, M Wetterslev, GK Vesterlund… - cric.nu
Background Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused a
pandemic of coronavirus disease (COVID-19) with many patients developing severe …

[HTML][HTML] Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID …

…, SM Jakob, L Cioccari, MBN Kjær, GK Vesterlund… - Intensive care …, 2022 - Springer
Purpose We compared dexamethasone 12 versus 6 mg daily for up to 10 days in patients
with coronavirus disease 2019 (COVID-19) and severe hypoxaemia in the international, …

Low‐dose hydrocortisone in patients with COVID‐19 and severe hypoxia: The COVID STEROID randomised, placebo‐controlled trial

…, M Wetterslev, GK Vesterlund… - Acta …, 2021 - Wiley Online Library
Background In the early phase of the pandemic, some guidelines recommended the use of
corticosteroids for critically ill patients with COVID‐19, whereas others recommended against …